Kazuhiro Tada

Kazuhiro Tada

Auto-generated profile, based on publicly available information

Kazuhiro Tada

Department of Surgery, Japanese Red Cross Oita Hospital, Oita, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2020 in Surgery Today
Verified
Journal Article
Closed access
PDF file
KTKazuhiro Tada
Kazuhiro Tada
MOMasayuki Ohta
Masayuki Ohta
SHShinya Hidano
Shinya Hidano
KWKiminori Watanabe
Kiminori Watanabe
THTeijiro Hirashita
Teijiro Hirashita
MIMasafumi Inomata
Masafumi Inomata

Verified
Journal Article
Open access
PDF file
KSKunihiro Saga
Kunihiro Saga
YIYukio Iwashita
Yukio Iwashita
SHShinya Hidano
Shinya Hidano
YAYuiko Aso
Yuiko Aso
KIKenji Isaka
Kenji Isaka
MIMasafumi Inomata
Masafumi Inomata
Hepatic stellate cells (HSCs) are key players in liver fibrosis, cellular senescence, and hepatic carcinogenesis. Bile acids (BAs) are involved in the activation of HSCs, but the detailed mechanism of this process remains unclear. We conducted a comprehensive DNA microarray study of the human HSC line LX-2 treated with deoxycholic acid (DCA), a secondary unconjugated BA. Additionally, LX-2 cells were exposed to nine BAs and studied using immunofluorescence staining, enzyme-linked immunosorbent assay, and flow cytometry to examine the mechanisms of HSC activation. We focused on the tumor necrosis factor (TNF) pathway and revealed upregulation of genes related to nuclear factor kappa B (NF-κB) signaling and senescence-associated secretory phenotype factors. α-Smooth muscle actin (α-SMA) was highly expressed in cells treated with secondary unconjugated BAs, including DCA, and a morphological change associated with radial extension of subendothelial protrusion was observed. Interleukin-6 level in culture supernatant was significantly higher in cells treated with secondary unconjugated BAs. Flow cytometry showed that the proportion of cells highly expressing α-SMA was significantly increased in HSCs cultured with secondary unconjugated BAs. We demonstrated that secondary unconjugated BAs induced the activation of human HSCs.

19 June 2018 in Japanese Journal of Clinical Oncology
Verified
Journal Article
Open access
PDF file
THTeijiro Hirashita
Teijiro Hirashita
MOMasayuki Ohta
Masayuki Ohta
KTKazuhiro Tada
Kazuhiro Tada
KSKunihiro Saga
Kunihiro Saga
HTHiroomi Takayama
Hiroomi Takayama
MIMasafumi Inomata
Masafumi Inomata
Non-ampullary duodenal adenocarcinoma, excluding carcinoma in the ampulla of Vater, is a rare disease. Although several prognostic factors have been reported, they remain controversial due to the rarity of non-ampullary duodenal adenocarcinoma. The aims of this study were to investigate prognostic factors in patients with non-ampullary duodenal adenocarcinoma and to assess chemotherapy in patients with recurrence. Records of 25 patients who underwent surgical treatment for non-ampullary duodenal adenocarcinoma from 2004 to 2016 were retrospectively reviewed. The relationship between the clinicopathological factors and outcomes was investigated. Serum level of CA19-9, gross appearance, tumor size, tumor invasion, lymph node metastases, TNM stage and lymphatic and vascular invasion were significant risk factors of recurrence. Patients with recurrence who received chemotherapy according to regimens used to treat colorectal cancer had a better prognosis than those without chemotherapy (P = 0.016). Advanced non-ampullary duodenal adenocarcinoma has a poor prognosis, but chemotherapy possibly improves the prognosis in the patients with recurrent non-ampullary duodenal adenocarcinoma.

19 July 2017 in Surgery Today
Verified
Journal Article
Closed access
PDF file
KTKazuhiro Tada
Kazuhiro Tada
MOMasayuki Ohta
Masayuki Ohta
KSKunihiro Saga
Kunihiro Saga
HTHiroomi Takayama
Hiroomi Takayama
THTeijiro Hirashita
Teijiro Hirashita
MIMasafumi Inomata
Masafumi Inomata

1 February 2024 in Internal Medicine
Verified
Journal Article
Open access
PDF file
TYTetsuhiko Yasuno
Tetsuhiko Yasuno
KTKoji Takahashi
Koji Takahashi
KTKazuhiro Tada
Kazuhiro Tada
HHHiroto Hiyamuta
Hiroto Hiyamuta
MWMaho Watanabe
Maho Watanabe
KMKosuke Masutani
Kosuke Masutani
Background The gut bacterial microbiota is altered in patients with chronic kidney disease (CKD). However, the bacterial composition at each stage of CKD is unclear in these patients, including those receiving renal replacement therapy. We herein report the changes in the gut microbiota among patients with CKD. Methods A total of 93 individuals were recruited for the study. Seventy-three patients had stage 3-5 CKD, including those receiving renal replacement therapy (CKD group), and 20 were age- and sex-matched controls (CKD stage 1-2). The gut microbiome composition was analyzed using a 16S ribosomal RNA gene-based sequencing protocol. Results At the genus level, the butyrate-producing bacteria Lachnospira, Blautia, Coprococcus, Anaerostipes, and Roseburia were more abundant in the control group (linear discriminant analysis score of >3) than in the CKD group. Lachnospira was more abundant in the control group than in patients with CKD stage 3a. Compared to the control group, multiplex butyrate-producing bacteria were deficient in patients with CKD stage 3b-5D, including in patients receiving renal replacement therapy. Conclusion Our findings highlight the fact that the gut bacterial composition, including butyrate-producing bacteria, deteriorates from CKD stage 3b. Even after renal replacement therapy, the bacterial composition did not change.

29 January 2019 in Annals of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
YEYuichi Endo
Yuichi Endo
MOMasayuki Ohta
Masayuki Ohta
KTKazuhiro Tada
Kazuhiro Tada
HNHiroaki Nakanuma
Hiroaki Nakanuma
KSKunihiro Saga
Kunihiro Saga
MIMasafumi Inomata
Masafumi Inomata
Purpose The purpose of this study was to evaluate changes in non‐alcoholic fatty liver disease (NAFLD) after laparoscopic sleeve gastrectomy (LSG) using computed tomography (CT) images. Methods We analyzed data from 57 patients who underwent LSG and had CTs performed before and after surgery. The patients included 34 women and 23 men (with an average age of 43 years); their mean preoperative weight and body mass index were 120 kg and 46 kg/m2, respectively. Obesity‐related health disorders included type 2 diabetes mellitus (T2DM) in 33 patients, hypertension in 33 and dyslipidemia in 32. We diagnosed NAFLD in cases with liver to spleen ratios (L/S ratio) <0.9 on non‐contrast CT images. We evaluated changes in body weights, BMIs, comorbidities, metabolic parameters, L/S ratios, and liver volumes after surgery. Results The mean interval between CT scans before and after surgery was 26 months. The total weight loss and % excess weight loss were 35 kg and 72%, respectively. The remission rates for T2DM, hypertension, and dyslipidemia were 85%, 76% and 84%, respectively. After LSG, the L/S ratio increased in all the patients, while all except for one had L/S ratio >0.9. We diagnosed 33 out of 57 patients (58%) as having NAFLD before the operation. After the operation, the L/S ratios and liver volumes were not statistically different between the patients with previous NAFLD and those without it. Conclusion Laparoscopic sleeve gastrectomy is an effective treatment for obesity‐related health disorders including NAFLD in Japanese obese patients.